Nutropin aq [somatropin (dna origin) injection]    (DrugBank: Somatropin)

1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis1

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 1,592 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00079742
(ClinicalTrials.gov)
September 200311/3/2004A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic FibrosisA Phase II, Multicenter, Randomized, Controlled, Open-Label Study of the Safety and Efficacy of Nutropin AQ [Somatropin (DNA Origin) Injection] for the Treatment of Growth Restriction in Children With Cystic FibrosisCystic FibrosisDrug: Nutropin AQ [somatropin (DNA origin) injection]Genentech, Inc.NULLCompleted5 Years13 YearsBoth68Phase 2United States